ATE471990T1 - Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln - Google Patents
Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikelnInfo
- Publication number
- ATE471990T1 ATE471990T1 AT02807461T AT02807461T ATE471990T1 AT E471990 T1 ATE471990 T1 AT E471990T1 AT 02807461 T AT02807461 T AT 02807461T AT 02807461 T AT02807461 T AT 02807461T AT E471990 T1 ATE471990 T1 AT E471990T1
- Authority
- AT
- Austria
- Prior art keywords
- papillomavirus
- virus
- particles
- transcutane
- immunization against
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31190101P | 2001-08-13 | 2001-08-13 | |
US37702302P | 2002-05-01 | 2002-05-01 | |
PCT/US2002/025391 WO2003103570A2 (en) | 2001-08-01 | 2002-08-09 | Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE471990T1 true ATE471990T1 (de) | 2010-07-15 |
Family
ID=29739302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02807461T ATE471990T1 (de) | 2001-08-13 | 2002-08-09 | Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln |
Country Status (7)
Country | Link |
---|---|
US (1) | US7247433B2 (de) |
EP (1) | EP1425423B1 (de) |
AT (1) | ATE471990T1 (de) |
AU (1) | AU2002367977B2 (de) |
CA (1) | CA2457804C (de) |
DE (1) | DE60236806D1 (de) |
WO (1) | WO2003103570A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1450856B1 (de) | 2001-09-14 | 2009-11-11 | Cytos Biotechnology AG | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG |
US20040137004A1 (en) * | 2002-03-19 | 2004-07-15 | Glenn Gregory M | Patch for transcutaneous immunization |
FR2887457B1 (fr) * | 2005-06-23 | 2007-10-05 | Fond Bettencourt Schueller | Vaccination par ciblage transcutane |
US8778351B2 (en) | 2006-08-30 | 2014-07-15 | University Of Rochester | Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors |
US8795235B2 (en) * | 2006-10-06 | 2014-08-05 | Surgiquest, Inc. | Devices for and methods of performing minimally-invasive surgical procedures through a single incision |
US10045860B2 (en) | 2008-12-19 | 2018-08-14 | Amicus Design Group, Llc | Interbody vertebral prosthetic device with self-deploying screws |
US9566165B2 (en) | 2012-03-19 | 2017-02-14 | Amicus Design Group, Llc | Interbody vertebral prosthetic and orthopedic fusion device with self-deploying anchors |
EP2827807B1 (de) | 2012-03-19 | 2019-12-11 | Amicus Design Group, LLC | Zwischenwirbelprothese und orthopädische fusionsvorrichtung mit selbstgesteuerten ankern |
WO2015024022A2 (en) | 2013-08-16 | 2015-02-19 | University Of Rochester | Designed peptides for tight junction barrier modulation |
WO2020247347A1 (en) | 2019-06-05 | 2020-12-10 | University Of Rochester | New designed inhibitors of tight junction formation |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0217919B1 (de) * | 1985-04-04 | 1992-08-05 | Georgetown University | Typenspezifische papillomavirus-dns-sequenzen und peptide |
DE69233687T2 (de) | 1991-07-19 | 2007-10-18 | University Of Queensland, St. Lucia | Impfstoff gegen Humanes Papillomavirus (Typ 18) |
WO1994000152A1 (en) | 1992-06-25 | 1994-01-06 | Georgetown University | Papillomavirus vaccines |
US5618536A (en) | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
US5437951A (en) | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
JPH08507685A (ja) | 1993-03-09 | 1996-08-20 | ユニバーシティ・オブ・ロチェスター | ひとパピローマウイルス・カプシド蛋白およびウイルス様粒子の製造 |
US6153201A (en) * | 1993-03-09 | 2000-11-28 | University Of Rochester | Oral immunization with papillomavirus virus-like particles |
US6599739B1 (en) | 1996-07-17 | 2003-07-29 | The United States Of America As Represented By The Department Of Health & Human Services | Infectious papillomavirus pseudoviral particles |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US6165471A (en) | 1997-07-03 | 2000-12-26 | University Of Colorado, University Technology Corporation | Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents |
US6228368B1 (en) | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
EP2286834A3 (de) | 1998-02-25 | 2012-01-25 | THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY | Verwendung von Mitteln zur Verbesserung der Hautpenetration und schrankenbrechenden Mitteln zur Verbesserung der transkutanen Immunantwort |
US6835184B1 (en) | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
AU784781B2 (en) | 1999-11-10 | 2006-06-15 | Powderject Vaccines, Inc. | Induction of mucosal immunity by vaccination via the skin route |
AU2001245552A1 (en) * | 2000-03-09 | 2001-09-17 | Emory University | Transcutaneous immunization for large particulate antigens |
US6595947B1 (en) * | 2000-05-22 | 2003-07-22 | Becton, Dickinson And Company | Topical delivery of vaccines |
US20020193729A1 (en) | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
-
2002
- 2002-08-09 US US10/486,564 patent/US7247433B2/en not_active Expired - Fee Related
- 2002-08-09 DE DE60236806T patent/DE60236806D1/de not_active Expired - Lifetime
- 2002-08-09 WO PCT/US2002/025391 patent/WO2003103570A2/en not_active Application Discontinuation
- 2002-08-09 AT AT02807461T patent/ATE471990T1/de not_active IP Right Cessation
- 2002-08-09 EP EP02807461A patent/EP1425423B1/de not_active Expired - Lifetime
- 2002-08-09 CA CA 2457804 patent/CA2457804C/en not_active Expired - Fee Related
- 2002-08-09 AU AU2002367977A patent/AU2002367977B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE60236806D1 (de) | 2010-08-05 |
US20050013832A1 (en) | 2005-01-20 |
WO2003103570A3 (en) | 2004-02-12 |
US7247433B2 (en) | 2007-07-24 |
AU2002367977B2 (en) | 2008-06-19 |
AU2002367977A1 (en) | 2003-12-22 |
EP1425423A2 (de) | 2004-06-09 |
EP1425423B1 (de) | 2010-06-23 |
WO2003103570A2 (en) | 2003-12-18 |
CA2457804A1 (en) | 2003-12-18 |
CA2457804C (en) | 2012-10-16 |
WO2003103570A9 (en) | 2004-05-06 |
EP1425423A4 (de) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE499113T1 (de) | Influenzavirus-impfstoffzusammensetzung | |
WO2007028047A3 (en) | Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy | |
ATE465750T1 (de) | Verwendung eines replikationdefizienten pockenvirusvektors zur erhöhung der cd4+ t-zell- immunantwort gegen antigen | |
ATE542829T1 (de) | Impfstoff | |
EP1504112A4 (de) | Entwicklung einer vakzine zur prävention von infektionen mit dem filovirus bei primaten | |
ATE471990T1 (de) | Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln | |
EP1471936A4 (de) | Hiv-vakzine und anwendungsverfahren | |
EA200701633A1 (ru) | Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1 | |
DE60011560D1 (de) | Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert | |
WO2007016715A3 (en) | Immune response inducing preparations | |
WO2006024240A3 (es) | Composición vacunal contra el virus de la hepatitis c. | |
DK1395283T3 (da) | Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine | |
EA200301151A1 (ru) | Вакцина против натуральной оспы | |
BRPI0414073A (pt) | método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo | |
ATE526035T1 (de) | Tollwut-impfstoff | |
ATE431745T1 (de) | Ltb4 als adjuvans für impfstoffe | |
AP2003002867A0 (en) | Immune response potentiation | |
WO2009114202A3 (en) | Vaccine and immunization method using plasmodium antigen 2 | |
TW200607812A (en) | Prevention, treament and detection of porcine progressive atrophic rhinitis | |
WO2004083390A3 (en) | Virulent systemic feline calicivirus | |
EA200702077A1 (ru) | Вакцина | |
ATE145335T1 (de) | Kreuzreaktive immunisierung gegen influenza | |
HUP0402548A2 (hu) | Madárembrió-részecskékből álló biomassza vírusantigének előállítására | |
AU2003294192A8 (en) | Inclusion bodies as antigens for the oral vaccination of animals | |
DE60233391D1 (de) | Vakzine zum schutz von tieren gegen leishmania |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |